Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT-Reference-Cited by-同舟云学术

Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT

Published:2022-02-01 Issue:4 Volume:57 Page:572-578
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Nagler Arnon^ORCID,Labopin Myriam^ORCID,Huang Xiao-jun^ORCID,Blaise Didier^ORCID,Arcese William,Araujo Mercedes Colorado,Socié Gerard^ORCID,Forcade Edouard^ORCID,Ciceri Fabio^ORCID,Canaani Jonathan,Giebel Sebastian^ORCID,Brissot Eolia,Caballer Jaime Sanz^ORCID,Bazarbachi Ali^ORCID,Yakoub-Agha Ibrahim^ORCID,Mohty Mohamad^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01537-x.pdf

Reference39 articles.

1. Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N. Engl J Med. 2015;373:1136–52.

2. Yates JW, Wallace HJ, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep. 1973;57:485–8.

3. Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, et al. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood. 1982;60:454–62.

4. Stein EM, Tallman MS. Remission induction in acute myeloid leukemia. Int J Hematol. 2012;96:164–70.

5. Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transpl. 2017;52:811.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core‐binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2024-04-24

2. Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study;Cancer;2024-04-06

4. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients;Leukemia;2022-10-30

5. Développements thérapeutiques en hématologie au XXIe siècle;Bulletin de l'Académie Nationale de Médecine;2022-10